Finance

Beta
Lists
688253:SHA
Innovita Biological Technology Co Ltd
CN¥58.97
+2.02%
(+1.17) 1D
Jun 15, 11:30:02 AM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688253...
Open
CN¥57.88
High
CN¥61.01
Low
CN¥57.88
Mkt. cap
7.92B
Avg. vol.
2.65M
Volume
1.53M
Dividend
0.76%
Quarterly dividend
CN¥0.11
Ex-dividend date
Jun 16, 2026
P/E ratio
89.51
52-wk high
CN¥68.50
52-wk low
CN¥29.99
EPS
CN¥0.66
No. of employees
571
Open
CN¥57.88
High
CN¥61.01
Low
CN¥57.88
Mkt. cap
7.92B
Avg. vol.
2.65M
Volume
1.53M
Dividend
0.76%
Quarterly dividend
CN¥0.11
Ex-dividend date
Jun 16, 2026
P/E ratio
89.51
52-wk high
CN¥68.50
52-wk low
CN¥29.99
EPS
CN¥0.66
No. of employees
571
News stories
From sources across the web
About Innovita Biological Technology Co Ltd
CEO-
Employees571
FoundedFeb 6, 2006
Headquarters-
SectorMedical device
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
69.46M
53.97M
91.63M
108.81M
Cost of goods sold
22.11M
14.59M
24.44M
25.72M
Cost of revenue
22.11M
14.59M
24.44M
25.72M
Research and development expenses
7.21M
18.80M
34.36M
18.06M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
21.38M
21.56M
27.19M
27.64M
Operating expense
28.54M
34.65M
63.66M
41.76M
Total operating expenses
50.66M
49.25M
88.11M
67.47M
Operating income
18.81M
4.72M
3.53M
41.34M
Other non operating income
74.57K
-579.01K
417.93K
-818.17K
EBT including unusual items
29.81M
5.53M
12.61M
46.00M
EBT excluding unusual items
23.80M
9.77M
9.10M
43.11M
Income tax expense
29.20K
-590.12K
-680.12K
5.37M
Effective tax rate
0.10%
-10.68%
-5.40%
11.67%
Other operating expenses
-52.91K
-814.33K
1.89M
1.22M
Net income
29.78M
6.12M
13.29M
40.63M
Net profit margin
42.87%
11.34%
14.50%
37.34%
Earnings per share
-
-
-
-
Interest and investment income
5.22M
5.41M
6.40M
2.65M
Interest expense
-32.74K
-51.23K
-50.93K
-54.50K
Net interest expenses
5.19M
5.36M
6.35M
2.59M
Depreciation and amortization charges
-
-
-
-
EBITDA
24.26M
9.39M
9.17M
46.98M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more